[Retracted] Effects of Fufang Banmao Capsule Associated with Sorafenib on Liver Function, Immune Status, Quality of Life Improvement, and Survival in Patients with Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study

Table 5

Comparison of tumor markers between groups ().

Grouping	N	AFP (pg/ml)		CEA (ng/L)		CA199 (ng/L)
		Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment
Observation group	72	197.08 ± 17.45	89.93 ± 10.24^a	36.06 ± 6.15	19.78 ± 3.05^a	86.54 ± 13.58	53.74 ± 9.28^a
Control group	72	201.18 ± 18.03	95.31 ± 11.87^b	35.58 ± 5.93	27.47 ± 3.41^b	85.67 ± 14.13	72.84 ± 10.46^b
t-value		1.387	2.912	0.477	14.263	0.377	11.590
P-value		＞0.05	＜0.05	＞0.05	＜0.05	＞0.05	＜0.05

Note. Compared to observation group before treatment, ^aP < 0.05. Compared to control group before treatment, ^bP < 0.05.